Lauren Gilstrap1,2,3, Weiping Zhou2, Marcella Alsan3,4, Anoop Nanda2, Jonathan S Skinner2,3. 1. Dartmouth-Hitchcock Medical Center, Heart and Vascular Center, Lebanon, New Hampshire. 2. The Dartmouth Institute, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire. 3. National Bureau of Economic Research, Cambridge, Massachusetts. 4. Harvard Kennedy School, Boston, Massachusetts.
Abstract
IMPORTANCE: The COVID-19 pandemic fundamentally altered the delivery of health care in the United States. The associations between these COVID-19-related changes and outcomes in vulnerable patients, such as among persons with Alzheimer disease and related dementias (ADRD), are not yet well understood. OBJECTIVE: To determine the association between regional rates of COVID-19 infection and excess mortality among individuals with ADRD. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study used data from beneficiaries of 100% fee-for-service Medicare Parts A and B between January 1, 2019, and December 31, 2020, to assess age- and sex-adjusted mortality rates. Participants were 53 640 888 Medicare enrollees 65 years of age or older categorized into 4 prespecified cohorts: enrollees with or without ADRD and enrollees with or without ADRD residing in nursing homes. EXPOSURES: Monthly COVID-19 infection rates by hospital referral region between January and December 2020. MAIN OUTCOMES AND MEASURES: Mortality rates from March through December 2020 were compared with those from March through December 2019. Excess mortality was calculated by comparing mortality rates in 2020 with rates in 2019 for specific, predetermined groups. Means were compared using t tests, and 95% CIs were estimated using the delta method. RESULTS: This cross-sectional study included 26 952 752 Medicare enrollees in 2019 and 26 688 136 enrollees in 2020. In 2019, the mean (SD) age of community-dwelling beneficiaries without ADRD was 74.1 (8.8) years and with ADRD was 82.6 (8.4) years. The mean (SD) age of nursing home residents with ADRD (83.6 [8.4] years) was similar to that for patients without ADRD (79.7 [8.8] years). Among patients diagnosed as having ADRD in 2019, 63.5% were women, 2.7% were Asian, 9.2% were Black, 5.7% were Hispanic, 80.7% were White, and 1.7% were identified as other (included all races or ethnicities other than those given); the composition did not change appreciably in 2020. Compared with 2019, adjusted mortality in 2020 was 12.4% (95% CI, 12.1%-12.6%) higher among enrollees without ADRD and 25.7% (95% CI, 25.3%-26.2%) higher among all enrollees with ADRD, with even higher percentages for Asian (36.0%; 95% CI, 32.6%-39.3%), Black (36.7%; 95% CI, 35.2%-38.2%), and Hispanic (40.1%; 95% CI, 37.9%-42.3%) populations with ADRD. The hospital referral region in the lowest quintile for COVID-19 infections in 2020 had no excess mortality among enrollees without ADRD but 8.8% (95% CI, 7.5%-10.2%) higher mortality among community-dwelling enrollees with ADRD and 14.2% (95% CI, 12.2%-16.2%) higher mortality among enrollees with ADRD living in nursing homes. CONCLUSIONS AND RELEVANCE: The results of this cross-sectional study suggest that the COVID-19 pandemic may be associated with excess mortality among older adults with ADRD, especially for Asian, Black, and Hispanic populations and people living in nursing homes, even in areas with low COVID-19 prevalence.
IMPORTANCE: The COVID-19 pandemic fundamentally altered the delivery of health care in the United States. The associations between these COVID-19-related changes and outcomes in vulnerable patients, such as among persons with Alzheimer disease and related dementias (ADRD), are not yet well understood. OBJECTIVE: To determine the association between regional rates of COVID-19 infection and excess mortality among individuals with ADRD. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cross-sectional study used data from beneficiaries of 100% fee-for-service Medicare Parts A and B between January 1, 2019, and December 31, 2020, to assess age- and sex-adjusted mortality rates. Participants were 53 640 888 Medicare enrollees 65 years of age or older categorized into 4 prespecified cohorts: enrollees with or without ADRD and enrollees with or without ADRD residing in nursing homes. EXPOSURES: Monthly COVID-19 infection rates by hospital referral region between January and December 2020. MAIN OUTCOMES AND MEASURES: Mortality rates from March through December 2020 were compared with those from March through December 2019. Excess mortality was calculated by comparing mortality rates in 2020 with rates in 2019 for specific, predetermined groups. Means were compared using t tests, and 95% CIs were estimated using the delta method. RESULTS: This cross-sectional study included 26 952 752 Medicare enrollees in 2019 and 26 688 136 enrollees in 2020. In 2019, the mean (SD) age of community-dwelling beneficiaries without ADRD was 74.1 (8.8) years and with ADRD was 82.6 (8.4) years. The mean (SD) age of nursing home residents with ADRD (83.6 [8.4] years) was similar to that for patients without ADRD (79.7 [8.8] years). Among patients diagnosed as having ADRD in 2019, 63.5% were women, 2.7% were Asian, 9.2% were Black, 5.7% were Hispanic, 80.7% were White, and 1.7% were identified as other (included all races or ethnicities other than those given); the composition did not change appreciably in 2020. Compared with 2019, adjusted mortality in 2020 was 12.4% (95% CI, 12.1%-12.6%) higher among enrollees without ADRD and 25.7% (95% CI, 25.3%-26.2%) higher among all enrollees with ADRD, with even higher percentages for Asian (36.0%; 95% CI, 32.6%-39.3%), Black (36.7%; 95% CI, 35.2%-38.2%), and Hispanic (40.1%; 95% CI, 37.9%-42.3%) populations with ADRD. The hospital referral region in the lowest quintile for COVID-19 infections in 2020 had no excess mortality among enrollees without ADRD but 8.8% (95% CI, 7.5%-10.2%) higher mortality among community-dwelling enrollees with ADRD and 14.2% (95% CI, 12.2%-16.2%) higher mortality among enrollees with ADRD living in nursing homes. CONCLUSIONS AND RELEVANCE: The results of this cross-sectional study suggest that the COVID-19 pandemic may be associated with excess mortality among older adults with ADRD, especially for Asian, Black, and Hispanic populations and people living in nursing homes, even in areas with low COVID-19 prevalence.
Authors: Katherine L Possin; Jennifer J Merrilees; Sarah Dulaney; Stephen J Bonasera; Winston Chiong; Kirby Lee; Sarah M Hooper; Isabel Elaine Allen; Tamara Braley; Alissa Bernstein; Talita D Rosa; Krista Harrison; Hailey Begert-Hellings; John Kornak; James G Kahn; Georges Naasan; Serggio Lanata; Amy M Clark; Anna Chodos; Rosalie Gearhart; Christine Ritchie; Bruce L Miller Journal: JAMA Intern Med Date: 2019-12-01 Impact factor: 21.873
Authors: Cyrus M Kosar; Elizabeth M White; Richard A Feifer; Carolyn Blackman; Stefan Gravenstein; Orestis A Panagiotou; Kevin McConeghy; Vincent Mor Journal: Health Aff (Millwood) Date: 2021-03-11 Impact factor: 6.301
Authors: Daniel M Weinberger; Jenny Chen; Ted Cohen; Forrest W Crawford; Farzad Mostashari; Don Olson; Virginia E Pitzer; Nicholas G Reich; Marcus Russi; Lone Simonsen; Anne Watkins; Cecile Viboud Journal: JAMA Intern Med Date: 2020-10-01 Impact factor: 21.873
Authors: Suparna Bagchi; Josephine Mak; Qunna Li; Edward Sheriff; Elisabeth Mungai; Angela Anttila; Minn Minn Soe; Jonathan R Edwards; Andrea L Benin; Daniel A Pollock; Evan Shulman; Shari Ling; Jean Moody-Williams; Lee A Fleisher; Arjun Srinivasan; Jeneita M Bell Journal: MMWR Morb Mortal Wkly Rep Date: 2021-01-15 Impact factor: 17.586
Authors: Clarissa Giebel; Kerry Hanna; Manoj Rajagopal; Aravind Komuravelli; Jacqueline Cannon; Justine Shenton; Ruth Eley; Anna Gaughan; Steve Callaghan; Hilary Tetlow; Stan Limbert; Rosie Whittington; Carol Rogers; Kym Ward; Lisa Shaw; Sarah Butchard; Mark Gabbay Journal: BMC Public Health Date: 2021-04-20 Impact factor: 3.295
Authors: Ashwin A Kotwal; Julianne Holt-Lunstad; Rebecca L Newmark; Irena Cenzer; Alexander K Smith; Kenneth E Covinsky; Danielle P Escueta; Jina M Lee; Carla M Perissinotto Journal: J Am Geriatr Soc Date: 2020-10-09 Impact factor: 7.538